Atenolol News and Research

RSS
Atenolol is a ß1 receptor specific antagonist, a drug belonging to the group of ß-blockers, a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and to treat and reduce the risk of heart complications following myocardial infarction (heart attack)
New treatment for Marfan syndrome works as well as beta blockers

New treatment for Marfan syndrome works as well as beta blockers

Investigational treatment shows promise against Marfan syndrome

Investigational treatment shows promise against Marfan syndrome

New joint ESC/ESA Guidelines on non-cardiac surgery

New joint ESC/ESA Guidelines on non-cardiac surgery

Beta blocker use linked to NSCLC patient survival

Beta blocker use linked to NSCLC patient survival

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Pay more than lip service to sun-screen advice for antihypertensive users

Pay more than lip service to sun-screen advice for antihypertensive users

Beta blockers do not reduce risk of colorectal cancer

Beta blockers do not reduce risk of colorectal cancer

Weight gain or loss may also depend on medicines taken

Weight gain or loss may also depend on medicines taken

AAN updated guideline on how to best treat essential tremor

AAN updated guideline on how to best treat essential tremor

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Some drug mixtures may be fatal for elderly: study

Some drug mixtures may be fatal for elderly: study

Shionogi launches CUVPOSA for pediatric chronic severe drooling

Shionogi launches CUVPOSA for pediatric chronic severe drooling

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

Tracking heart rate can provide important marker of health issues: Research

Tracking heart rate can provide important marker of health issues: Research

Shionogi's CUVPOSA receives FDA approval for treatment of chronic severe drooling

Shionogi's CUVPOSA receives FDA approval for treatment of chronic severe drooling

Hypertension: Regular nifedipine administration may lead to development of GERD

Hypertension: Regular nifedipine administration may lead to development of GERD

Drugs and fruit juices - a combination to avoid

Drugs and fruit juices - a combination to avoid

New reasons to avoid grapefruit juice when taking certain drugs

New reasons to avoid grapefruit juice when taking certain drugs